PINK1/Parkin-mediated mitophagy has been proposed as a pathway containing modulatable targets for drug discovery strategies aimed at enhancing mitophagy in various diseases, including ageing and PD [17–20]. This evidence concerns the gene PRKN and Parkinson disease.